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INTRODUCTION
Lung size mismatch between donor and recipient is a major 
cause of poor lung function and worse survival after lung trans-
plantation (LTx). However, controversy remains regarding the 
definition of proper size and the optimal method for predict-
ing lung size.1-4 
Although thoracic diameter, chest radiography, anthropom-
etry, weight, and other factors have been used to predict lung 
volume in the past,5-7 lung volume is now commonly calculat-
ed by formulas that utilize height, age, and sex.1,8 These formu-
las are modified and differ among nations and institutes.9,10 
Moreover, the predictive total lung capacity (pTLC) calculated 
by these formulas differs among races11 and has disadvantag-
es when applied to single LTx candidates. Also, since LTx can-
didates have variable thoracic cavity volumes according to their 
lung diseases, it is difficult to estimate their lung volumes us-
ing formulas that target the healthy population.12
This study aimed to determine the degree of differences in 
actual TLC (TLCCT) using chest computed tomography (CT) 
and the pTLC using the commonly used formula in LTx candi-
dates. Through this comparison, this study also intended to 
clarify the range of difference needed for donor lung selection 
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when using formulas to perform lung size matching.
MATERIALS AND METHODS
Patients
From January 1996 to December 2012, medical records and 
chest CT scans of 140 patients registered as lung transplant can-
didates at Gangnam Severance Hospital were retrospectively 
analyzed. This study received approval from the Institutional 
Review Board at Gangnam Severance Hospital. We excluded 
patients with incomplete medical records, lacking results of a 
pulmonary function test (PFT) or CT image, and with a history 
of any thoracic surgery except lung biopsy.
pTLC calculation
In this study, pTLC was calculated using European Respirato-
ry Society (ERS) formulas, which are as follows:13
Males: pTLC (mL)=(7.99 H–7.08)×1000; and
Females: pTLC (mL)=(6.60 H–5.79)×1000, where H repre-
sents height in meters.
These equations apply to patients aged 18–70 years with a 
height of 1.55–1.95 m (males) or 1.45–1.80 m (females). 
Pulmonary function test
Using spirometry, the forced expiratory volume in 1 second 
(FEV1) and forced vital capacity (FVC) were measured. Next, 
FEV1/FVC ratio was calculated. Knudson prediction equations 
derived from a patient’s age, height, and sex, were applied to the 
predicted values and the lower limits of normal.14 The patients’ 
lung disease patterns were classified as obstructive disease pat-
tern (OD group) or restrictive disease pattern (RD group) ac-
cording to measured FEV1, FVC, and FEV1/FVC ratio (Fig. 1).15
CT protocol and volumetry analysis
Using a 64-slice CT system (SOMATOM Sensation 64; Siemens 
AG, Forchheim, Germany), routine non-enhanced CT with 
parameters of 130 mA and 100 kVp scanned lungs from the pos-
terior costophrenic angles to the lung apices (3-mm beam col-
limation; 1.0 pitch). Raw data were processed using a medium 
soft-tissue kernel without edge enhancement. The scans were 
acquired during a single respiratory pause at the end of a max-
imum inspiratory effort. Patients were placed in a supine po-
sition.
The lung volume in each CT dataset was measured using semi-
automated segmentation software (Aquarius Intuition; Tera Re-
con Inc., Foster City, CA, USA). Threshold limits of -400 to 
-1024 Hounsfield units were applied to exclude the surround-
ing soft tissues and large vessels within the lungs.16 In most in-
stances, this would be sufficient for isolating the lungs and 
central airways from undesired structures. TLCCT (L) was ob-
tained by the number of included voxels in both lungs on the 
CT images (Fig. 2). 
Comparison of pTLC and TLCCT
Through a comparison of pTLC calculated using the ERS equa-
tion and TLCCT measured using chest CT, differences between 
OD and RD groups were investigated by PFT.
Statistical analysis
All data were presented as mean±standard deviation. The dif-
ference in the sex ratio between the two groups was calculated 
using the Fisher’s exact test, whereas the Mann-Whitney U test 
FEV1/FVC<lower limit of normal?
Restrictive or normal pattern
FVC<lower limit of normal?
Obstructive pattern
No
No
Normal
Yes
Yes
Restrictive pattern
Fig. 1. Flow chart for interpretation of pulmonary function tests. On the 
basis of FEV1, FVC, and FEV1/FVC ratio measured by spirometry, the lung 
disease patterns were classified into obstructive and restrictive pat-
terns. FEV1, forced expiratory volume in 1 second; FVC, forced vital ca-
pacity.
Fig. 2. Three-dimensional (3D) CT volume rendered image to measure 
TLC segmented by pixel attenuation thresholds. The lung parenchyma 
was semi-automatically extracted from CT data sets using commercial 
analysis software. Total volume of low-attenuating pixels (between -400 
to -1024 HU) within the extracted lung parenchyma was considered as 
the TLC. The figure above comprises a 3D CT image representing the 
TLC in a 60-year-old man with restrictive lung disease pattern accord-
ing to spirometry results. CT, computed tomography; HU, Hounsfield 
unit; TLC, total lung capacity.
965http://dx.doi.org/10.3349/ymj.2016.57.4.963
Sung Ho Hwang, et al.
was used to measure the other variables. All p-values<0.050 
were considered statistically significant. All statistical analyses 
were performed using SPSS software, version 20.0 (IBM, 
Somers, NY, USA).
RESULTS
Among the 140 candidate patients, only 104 satisfied the study 
criteria. There were 35 patients (38%) in the OD group and 57 
patients (62%) in the RD group. Twelve patients with mixed pat-
tern of OD and RD were excluded in analysis. There was no 
significant difference in sex ratios (p=0.197). Age was signifi-
cantly lower in the OD group than in the RD group (p<0.0001). 
While height did not differ between the groups (p=0.524), body 
weight was lower in the OD group than in the RD group (p= 
0.035) (Table 1).
Regarding diseases in each group, bronchiectasis was the 
most common, followed by lymphangioleiomyomatosis and 
chronic obstructive pulmonary disease (COPD), in the OD 
group, whereas idiopathic pulmonary fibrosis (IPF) was most 
common in the RD group (Fig. 3).
The values of pTLC were 5.50±1.07 L and 5.57±1.03 L in the 
OD and RD groups respectively, which were not significantly 
different (p=0.749). However, the TLCCT of the OD group 
(4.27±1.38 L) was significantly larger than that for the RD group 
(3.17±1.15 L) (p<0.0001). 
In comparison of pTLC and TLCCT, the values of pTLC were 
significantly larger than TLCCT regardless of groups (p<0001). 
Also, the difference values (ΔTLC) between pTLC and TLCCT 
were 2.02±1.07 L in the RD group and 1.13±1.19 L in the OD 
group, respectively, a statistically significant difference (p=0.001). 
The ratios of TLCCT to pTLC were 77.0% in the OD group and 
57.1% in the RD group (Table 2). 
DISCUSSION
Size mismatch between a donor lung allograft and a recipient 
thoracic cavity in LTx can cause many complications, includ-
ing poor lung function and decreased long-term survival.3,17,18 
Therefore, proper lung size matching has clinical significance 
in LTx.19,20 When a donor lung is far smaller than the recipient’s 
thoracic cavity, the risks of prolonged tube drainage or empy-
ema increase. Also, lung compliance decreases when a graft 
hyper-expands to fill the thoracic cavity. Conversely, when a 
donor lung is much larger than a recipient’s thoracic cavity, at-
electasis or distortion of the airway anatomy prohibits sputum 
expectoration and causes recurrent infection. Even in severe 
cases, hemodynamic compromise can occur.21 
Calculations of pTLC for donors and recipients with formu-
las are widely used in current lung size matching procedures 
for LTx, and such formulas are derived from sex, height, and 
age data of healthy individuals.1,13,22 However, because thoracic 
cavity volume can vary according to a patient’s lung disease pat-
tern,23 the use of these formulas in lung size matching for LTx 
Table 1. Clinical Characteristics of 92 Candidates for Lung Transplantation 
OD group RD group p value
Number 35 (38%) 57 (62%)
Gender 0.197
Male 14 32
Female 21 25
Age (yrs) 42.4±13.7 53.4±9.4 <0.0001
Height (cm) 164.3±8.6 163.2±8.4 0.524
Weight (kg) 51.3±13.0 57.3±13.5 0.035
OD, obstructive disease; RD, restrictive disease.
Table 2. Comparison of TLC between the OD and RD Groups
OD group RD group p value
pTLC (liter) 5.50±1.07 5.57±1.03 0.749
TLCCT (liter) 4.27±1.38 3.17±1.15 <0.0001
ΔTLC (liter) 1.13±1.19 2.02±1.07 0.001
TLCCT/pTLC (%) 77.0 57.1
OD, obstructive disease; RD, restrictive disease; pTLC, predicted total lung 
capacity; TLCCT, TLC estimated using chest computed tomography; ΔTLC, dif-
ference value between pTLC and TLCCT.
Bronchiectasis (n=11, 31.4%)
LAM (n=9, 25.7%)
COPD/emphysema (n=5, 14.3%)
Others (n=10, 28.6%)
IPF (n=43, 75.4%)
ARDS (n=3, 5.3%)
Systemic sclerosis (n=2, 3.5%)
Others (n=9, 15.8%)
A B
Fig. 3. Disease distribution according to pulmonary disease pattern. (A) Obstructive disease pattern. (B) Restrictive disease pattern. ARDS, acute re-
spiratory distress syndrome; COPD, chronic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis; LAM, lymphangioleiomyomatosis.
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has several problems: for example, in patients with obstruc-
tive lung diseases, such as COPD or emphysema, the thoracic 
cavity size increases, compared with the normal thoracic cavi-
ty size, by diaphragmatic flattening and widening of the rib 
spaces,24 whereas in patients with restrictive lung disease, such 
as IPF, thoracic cavity size decreases due to chest wall shrinkage 
and contraction of the intercostal spaces.12 However, studies on 
degrees of size mismatch by lung diseases patterns are rare. 
Moreover, there is no clear evidence to demonstrate that lung 
disease pattern should be considered in lung size matching pri-
or to LTx.
In evaluation of LTx candidates, most patients undergo a 
chest CT, by which the thoracic cavity volume can be mea-
sured,24 and recently three-dimensional CT volumetry has been 
utilized for size matching in living donor LTx.25,26 In this study, 
lung diseases of LTx candidates were classified as either an ob-
structive or restrictive disease pattern according to the results 
of PFT. By comparing TLCCT measured using chest CT and 
pTLC calculated using the ERS equation, we intended to inves-
tigate differences between TLCCT and pTLC in LTx candidates 
and to determine whether we should consider lung disease 
patterns in size matching. Our results revealed no difference 
between the two groups in pTLC, whereas TLCCT was signifi-
cantly larger in the OD group than in the RD group. These re-
sults suggest that actual lung volume may differ according to 
lung disease pattern and it is inappropriate to perform lung 
size matching with equations derived from data for healthy 
populations. Accordingly, we should consider the effect of lung 
disease when matching donor and recipient lung sizes.
The difference value between pTLC and TLCCT was statisti-
cally greater in the RD group than the OD group, and the ratio 
of TLCCT to pTLC was 77% in the OD group and 57% in the RD 
group. That is, irrespective of lung disease patterns, pTLC was 
larger than TLCCT. This finding might be attributed to differenc-
es among races, because we used the ERS equation for Europe-
an in this study. Hence, when equations are applied to lung 
size matching, racial differences should be considered. 
This study has several limitations. First, it is questionable 
whether the TLCCT could be substituted for the patient’s actual 
TLC. As TLC measured by PFT represents the functional as-
pect and TLCCT provides the anatomical lung volume, a differ-
ence could exist between the two values. However, Cooper, et 
al.27 demonstrated that TLC values measured using the helium 
dilution technique and those measured by chest CT were quite 
similar (r=0.973).28 Secondly, TLCCT can change during respi-
ration. In LTx candidates with end-stage lung disease, breath-
holding is difficult; hence, error in measuring TLCCT could be 
exaggerated, compared with that in healthy people. However, 
since current CT equipment involves a single scan that is com-
pleted in a few seconds, patients with lung disease do not ex-
perience great difficulty.
In conclusion, regardless of lung disease pattern, TLCCT was 
smaller than pTLC calculated using a formula, and the differ-
ence was more remarkable in patients with the restrictive lung 
disease. Therefore, when an equation is used for donor-recipi-
ent lung size matching, the difference between TLCCT and pTLC 
and lung disease pattern of LTx candidates should be consid-
ered. Additionally, chest CT might be a more accurate tool for 
measuring TLC than an equation in lung size matching for LTx.
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